The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...

Now, researchers have developed a new tool that could make painful biopsies a thing of the past—a small patch made of ...

Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression, Cancer Cell, June 2025 DOI: (25)00253-3 ...

Non-invasive epithelial tumors of the ovary that show abnormal cell growth but lack the capacity to invade surrounding ...

An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, ...

A Montreal researcher recently received a major $1.2 million grant from the Canadian Institutes of Health Research to better understand glioblastoma, a particularly aggressive and lethal form of brain ...

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is classifying the clinical mass spectrometry microorganism identification and differentiation system into class II (special controls ...

At this week’s American Society for Mass Spectrometry (ASMS) Conference in Baltimore, Maryland, Sciex presented updates to its mass spectrometry product lineup, focusing on tools for quantitative ...

With the new Proteograph workflow, Seer achieves a transformative milestone by significantly improving the scalability, reproducibility, and affordability of deep proteomic analysis. These ...

The precursor analyte was detected with a ~78,000 FWHM mass resolution putatively identified as Acetaminophen Glucuronide with a 0.09 ppm mass accuracy (theoretical mass: 328.10269).

Mass spectrometry imaging (MSI) is a powerful technology used to define the spatial distribution and relative abundance of metabolites across tissue cryosections. While software packages exist for ...